|
||
|
|
||
|
|
||
A
Brief Introduction to Antigenic Variation Many
viruses, bacteria and parasites have developed ways of
evading our immune systems. Each year we are hit by new
strains of influenza virus, which have mutated so they are
no longer destroyed by the antibodies and T-cells that we
developed to a previous infection. The African trypanosomes
infect our blood, organs and tissues but, unlike viruses,
they do not invade our cells. Therefore, they are
continuously exposed to the antibodies that we generate
against them, and which also circulate in our
bloodstream. In fact,
most of the circulating trypanosomes are successfully
destroyed by these antibodies. The problem is that there are
always survivors: trypanosomes that change their identity so
they are not recognized by the current wave of antibodies.
Unlike influenza or other viruses or bacteria, which need
time to mutate to avoid destruction, trypanosomes have
evolved a built-in system that quickly switches the antigens
against which our immune system produces
antibodies. This process
is called Antigenic
Variation,
and has been most extensively investigated in
Trypanosoma
brucei,
which is relatively easy to grow and study in the
laboratory. Trypanosoma brucei is mainly a veterinary
problem, but this species has two practically
indistinguishable relatives, Trypanosoma
rhodesiense
and Trypanosoma
gambiense,
which cause virulent or chronic infections, respectively, in
humans. The graph to
the left is redrawn from a report published in 1910, by Ross
and Thomson, of the progress of a human infection with
Trypanosoma gambiense. Despite repeated drug treatment, this
patient eventually died, as do probably all humans and
domestic animals infected with this virulent organism, in
the absence of treatment.

What the graph shows is that if one measures the number of
trypanosomes circulating in the bloodstream (the
parasitemia) at daily intervals, one detects a remarkable
periodicity. This is due to antigenic variation. As the
trypanosomes multiply (which they do by dividing into two
daughter cells, about every 8 hours), we make antibodies
against them. After 5 to 7 days, these antibodies destroy
most of the trypanosomes, and the parasitemia decreases, but
a new wave of trypanosomes appears. These are unaffected by
antibodies generated against the previous wave, so the
immnune system has to start over again. This process
continues essentially indefinitely, until the death of the
host. During this time, we continue to make primary
responses against new antigens. One consequence of this is
that our immune system becomes quite exhausted and our blood
levels of immunoglobulin M go sky high, to no useful
effect.
What are
these antigens and how do they switch so easily? The first
clue came from electron microscopy of trypanosomes. In 1979,
Keith Vickerman drew attention to a feature of the surface
of infective forms of Trypanosoma brucei. This was the
presence of a Surface
Coat, a
regular dense structure that surrounded the entire cell body
and flagellum of the trypanosome. Vickerman suggested that
the Surface
Coat
might contain the antigens responsible for antigenic
variation. The picture
shows a thin slice through a trypanosome viewed in an
electron microscope. The Surface
Coat is
represented by the fuzzy black outline of the cell in this
photograph. It can be seen in more detail in a
higher
magnification of the boxed area. We
discovered that the Surface
Coat of
every individual trypanosome is formed by 10 million copies
of a single molecular species of antigen. These antigens are
called glycoproteins, because they consist of a protein
backbone with sugar (glyco) attachments. To
Switch its Surface Coat,
the trypanosome can select any member of a large family of
what we call the Variant
Surface Glycoprotein
(VSG)
family. It is the frequent switching of
the
VSG
forming the Surface
Coat
that accounts for antigenic variation. Each
VSG
is encoded by an individual VSG
Gene.
Trypanosoma brucei contains hundreds of VSG
Genes,
accounting for about 10% of all its genes. If this system
could be disrupted, our immune systems might be able to
eliminate trypanosome infections. Much of our research is
directed toward understanding how trypanosomes regulate
antigenic variation. Trypanosomes
appear to exert tight control over the expression of VSG
genes. We don't know why this is so important to them, but
it might be an intrinsic side effect of the switching
mechanisms that the trypanosome has evolved. One of the
central
questions,
therefore, is how does the trypanosome express only one of
the hundreds of VSG genes at any time in any individual
cell? Two important subsidiary
questions
are what regulates the timing of a switch and what regulates
the order in which VSG genes are expressed? This kind of
'allelic choice' is not unique to trypanosomes. For example,
detection of odors in the noses of animals involves the use
of a large family of odorant receptors, but each sensory
cell in the nose expresses only one member of this family,
despite containing all of the genes. There are other
examples, in animals, of cells that are able to selectively
express single genes from families of various
complexity. In
trypanosomes, the VSG gene that is expressed is always
located very close to the end of a chromosome (a telomere).
This is a necessary but not sufficient condition to be
expressed because about 20 telomeres contain VSG genes in
the necessary configuration to be expressed (trypanosomes
have two copies of at least 11 chromosomes, hence they have
at least 44 telomeres). In some respects, this location
requirement reduces the complexity of the
exclusiveness question
to why is only one out of 20 telomeric VSG genes
expressed. We know
there are two main mechanisms by which a VSG gene can be
switched. One can switch the telomeric Expression
Site
that is being transcribed or one can shuttle VSG genes, from
other locations in the chromosomes, into an active
Expression
Site.
More technical details of these mechanisms can be found
elsewhere
on this site. This space is reserved for a future VSG picture.
